# Allergic Rhinitis: Developing Drug Products for Treatment Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/allergic-rhinitis-developing-drug-products-for-treatment-guidance-for-industry/dcca7128-d84a-436f-83a2-e705904c701f

> FDA guidance document: Allergic Rhinitis: Developing Drug Products for Treatment Guidance for Industry. Issue date: September 06, 2018. Get complete insights and analysis.

---

## Details

- Title: Allergic Rhinitis: Developing Drug Products for Treatment Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2018-09-06
- Last Changed: 2024-04-11
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2000-D-0277">FDA-2000-D-0277</a>

## Related Documents

- [Hypertension: Developing Fixed-Dose Combination Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/hypertension-developing-fixed-dose-combination-drugs-for-treatment/1a5d992e-fb16-402a-8d7a-11d62e5e766f)
- [Nonallergic Rhinitis:  Developing Drug Products for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/nonallergic-rhinitis-developing-drug-products-for-treatment/5453a88f-6b6b-4771-8248-e324727993ad)
- [Migraine: Developing Drugs for Acute Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/migraine-developing-drugs-for-acute-treatment/39ba4b4b-6c93-4849-a087-866c6bf4edff)